Binding of RHOA G17V to p300 enhances its HAT activity: a new mechanism of epigenetic deregulation in TFH lymphoma

David Vallois, Mélanie Juilland, Kalliopi Ioannidou, François Lemonnier, Edoardo Missiaglia, Bettina Bisig, Margot Thome, Laurence de Leval

Open source

DOI
10.1182/bloodadvances.2024014671
Published
2025-06-16
Container
Blood Advances
Publisher
American Society of Hematology
Open access
unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1182/bloodadvances.2024014671,
  title = {Binding of RHOA G17V to p300 enhances its HAT activity: a new mechanism of epigenetic deregulation in TFH lymphoma},
  author = {David Vallois and Mélanie Juilland and Kalliopi Ioannidou and François Lemonnier and Edoardo Missiaglia and Bettina Bisig and Margot Thome and Laurence de Leval},
  year = {2025},
  journal = {Blood Advances},
  doi = {10.1182/bloodadvances.2024014671},
  url = {https://doi.org/10.1182/bloodadvances.2024014671}
}

RIS

TY  - JOUR
TI  - Binding of RHOA G17V to p300 enhances its HAT activity: a new mechanism of epigenetic deregulation in TFH lymphoma
AU  - David Vallois
AU  - Mélanie Juilland
AU  - Kalliopi Ioannidou
AU  - François Lemonnier
AU  - Edoardo Missiaglia
AU  - Bettina Bisig
AU  - Margot Thome
AU  - Laurence de Leval
PY  - 2025
JO  - Blood Advances
DO  - 10.1182/bloodadvances.2024014671
UR  - https://doi.org/10.1182/bloodadvances.2024014671
ER  - 

APA

Vallois, D., Juilland, M., Ioannidou, K., Lemonnier, F., Missiaglia, E., Bisig, B., Thome, M., & Leval, L. D. (2025). Binding of RHOA G17V to p300 enhances its HAT activity: a new mechanism of epigenetic deregulation in TFH lymphoma. Blood Advances. https://doi.org/10.1182/bloodadvances.2024014671

Source records